How much has 858 Therapeutics raised?
$110.0Macross 3 recorded rounds · Mar 2020 – Jun 2024
Most recently, 858 Therapeutics raised $25.2M in its Early Stage VC (Jun 2024).
Free account
More of 858 Therapeutics with a free account
- ·Watch 858 Therapeutics: the Monday email on marks, rounds and moves
858 Therapeutics round by round
3 rounds12 investors participated
6 investors participated
1 investors participated
How much has 858 Therapeutics raised?
858 Therapeutics has raised $110 million across 3 recorded rounds since 2020. The largest was a $25.2 million early-stage round in Jun 2024.
858 Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Jul 2024 ($25.2 million sold to 12 investors).
858 Therapeutics investors
8 investors are on record for 858 Therapeutics, including Insight Partners (New York), New Enterprise Associates, Alexandria Venture Investments and Mirae Asset Capital. By type, the record holds 4 venture capital firms, 1 hedge fund and 1 asset manager. The early-stage round in Jun 2024 drew 12 investors.
For fundraisers
Raising for a company like 858 Therapeutics?
8 investors have backed 858 Therapeutics.
Frequently asked about 858 Therapeutics
- How much has 858 Therapeutics raised?
- 858 Therapeutics has raised $110.0M in total across 3 recorded funding rounds.
- When was 858 Therapeutics's last funding round?
- 858 Therapeutics's most recent recorded round was Early Stage VC in Jun 2024, raising $25.2M.